Publication Beamlines Strategic Pillar
Stobbs, Jarvis A.; Ghazani, Saeed M.; Donnelly, Mary-Ellen; Marangoni, Alejandro G. (2025). Chocolate Tempering: A Perspective. Crystal Growth and Design . 10.1021/acs.cgd.5c00269. BMIT-BM, BXDS-WLE Agriculture
Stobbs, Jarvis A.; Ghazani, Saeed M.; Tu, Kaiyang; Pensini, Erica; Fameau, Anne-Laure et al. (2025). Dimyristoylphosphoethanolamine Addition During Chocolate Manufacture Promotes Proper Tempering under Simple Cooling Conditions without Shear. Crystal Growth and Design 25(12) , 4621-4635. 10.1021/acs.cgd.5c00575. BMIT-BM, BXDS-WLE, EIML, MID-IR Agriculture
Teng, Youchao; Zhang, Zhilei; Cui, Yunqi; Su, Zhe; Godwin, Matthew et al. (2025). High‐Sensitivity and Flexible Motion Sensing Enabled by Robust, Self‐Healing Wood‐Based Anisotropic Hydrogel Composites. Small . 10.1002/smll.202500944. BXDS-WLE Materials
Yox, Philip; Teeter, Glenn; Baker, Lucas; Whitney, Drew; Maughan, Annalise E. et al. (2025). Directing Ion Transport and Interfacial Chemistry in Pnictogen-Substituted Thio-LISICONs. ACS Applied Materials and Interfaces . 10.1021/acsami.4c22390. BXDS-WHE, BXDS-WLE Materials
Yu, Svena; Bond, Toby; Rahemtulla, Al; Leontowich, Adam F. G.; Thompson, Daphne et al. (2025). In‐Situ Heating X‐Ray Diffraction of LiNi0.6Mn0.3Co0.1O2 and LiNi0.7Mn0.3O2 Made Using the All‐Dry Synthesis Process. Small Methods . 10.1002/smtd.202500632. BXDS-WLE Materials
Wang, Alana O.; Ptacek, Carol J.; Wilson, David; Blowes, David W. (2025). Geochemical stability of vitrified glass prepared from arsenic trioxide roaster waste from the Giant Gold Mine (Yellowknife, NT). Journal of Hazardous Materials 493, 138098. 10.1016/j.jhazmat.2025.138098. CLS-APS, HXMA Environment
Mundboth, Kiran (2025). Canadian Light Source – 20 Years of Discovery. Canadian Journal of Chemistry . 10.1139/cjc-2024-0278. BMIT, BXDS, CMCF, FAR-IR, HXMA, MID-IR, SM Health
Sankhe, Safiétou; Fofana, Fatoumata G.; Heiba, Walid; Ogunyemi, Oludare M.; Masisi, Kabo et al. (2025). BioStruct-Africa’s capacity building workshops as a model for advancing the emerging community of structural biologists in Africa. Communications Chemistry 8(1) . 10.1038/s42004-025-01519-w. CMCF Health
Colussi, Danielle M.; Grainger, Ryan; Noble, Megan; Lake, Taylor; Junop, Murray et al. (2025). Disrupting the network of co-evolving amino terminal domain residues relieves mitochondrial calcium uptake inhibition by MCUb. Computational and Structural Biotechnology Journal 27, 190-213. 10.1016/j.csbj.2024.12.007. [PDB: 8urg] CMCF-BM Health
Cottrell, Kevin M.; Briggs, Kimberly J.; Tsai, Alice; Tonini, Matthew R.; Whittington, Douglas A. et al. (2025). Discovery of TNG462: A Highly Potent and Selective MTA-Cooperative PRMT5 Inhibitor to Target Cancers with MTAP Deletion. Journal of Medicinal Chemistry 68(5) , 5097-5119. 10.1021/acs.jmedchem.4c03067. [PDB: 9n3o] CMCF-BM Health
Krishnan, Shreya S; Shen, Yao; O’Hagan, Treasa B; Matthews, Lindsay A; Weerasinghe, Nuwani W et al. (2025). Asymmetric loading of TnsE regulates Tn7 targeting of DNA replication structures. Nucleic Acids Research 53(11) . 10.1093/nar/gkaf472. CMCF-BM Health
Lee, Eunjeong; Tran, Norman; Redzic, Jasmina S.; Singh, Harmanpreet; Alamillo, Lorena et al. (2025). Identifying and controlling inactive and active conformations of a serine protease. Science Advances 11(15) . 10.1126/sciadv.adu7447. [PDB: 9bsh, 9bsm] CMCF-BM Health
Throner, Scott; Feng, Tianshu; Andersen, Jannik N.; Bandi, Madhavi; Engel, Justin L. et al. (2025). Discovery of TNG-6132, a potent, selective, and orally bioavailable USP1 inhibitor. Bioorganic and Medicinal Chemistry Letters 124, 130262. 10.1016/j.bmcl.2025.130262. [PDB: 9n9y] CMCF-BM Health
Tran, Norman; Redzic, Jasmina S.; Eisenmesser, Elan Z.; Holyoak, Todd (2025). The structure of the Gemella haemolysans M26 IgA1 protease trypsin-like domain. Acta Crystallographica Section F:Structural Biology Communications 81(4) . 10.1107/s2053230x25001219. [PDB: 9ect] CMCF-BM Health
Cregg, James; Edwards, Anne V.; Chang, Stephanie; Lee, Bianca J.; Knox, John E. et al. (2025). Discovery of Daraxonrasib (RMC-6236), a Potent and Orally Bioavailable RAS(ON) Multi-selective, Noncovalent Tri-complex Inhibitor for the Treatment of Patients with Multiple RAS-Addicted Cancers. Journal of Medicinal Chemistry . 10.1021/acs.jmedchem.4c02314. [PDB: 9bg0, 9bg2, 9bg3, 9bg4, 9bg5, 9bg6, 9bg8, 9bga, 9bgb, 9bgc, 9bgd] CMCF-ID Health